Moneycontrol
Close Ad
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Ajanta Pharma

Ajanta Pharma

BSE: 532331|NSE: AJANTPHARM|ISIN: INE031B01049|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 25, 16:00
1040.85
5.55 (0.54%)
VOLUME 34,592
LIVE
NSE
Jun 25, 15:56
1040.30
2 (0.19%)
VOLUME 711,636
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Quarterly Results of Ajanta Pharma

------------------- in Rs. Cr. -------------------
Mar '18 Dec '17 Sep '17 Jun '17 Mar '17
Net Sales/Income from operations 462.60 500.78 469.14 397.93 397.81
Other Operating Income -- -- -- -- 20.69
Total Income From Operations 462.60 500.78 469.14 397.93 418.50
EXPENDITURE
Consumption of Raw Materials 113.22 87.27 81.14 93.80 79.14
Purchase of Traded Goods 13.44 26.34 14.64 18.59 15.55
Increase/Decrease in Stocks -32.55 4.95 10.84 -32.39 -5.99
Power & Fuel -- -- -- -- --
Employees Cost 96.76 84.20 82.15 79.78 69.09
Depreciation 15.92 14.34 13.95 12.93 18.87
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 156.32 144.44 122.93 128.08 118.82
P/L Before Other Inc. , Int., Excpt. Items & Tax 99.49 139.24 143.49 97.14 123.02
Other Income 6.00 64.69 7.93 4.70 7.36
P/L Before Int., Excpt. Items & Tax 105.49 203.93 151.42 101.84 130.38
Interest 0.05 0.10 0.05 0.04 0.74
P/L Before Exceptional Items & Tax 105.44 203.83 151.37 101.80 129.64
Exceptional Items -- -- -- -- --
P/L Before Tax 105.44 203.83 151.37 101.80 129.64
Tax 26.94 39.24 43.67 25.07 21.67
P/L After Tax from Ordinary Activities 78.50 164.59 107.70 76.73 107.97
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 78.50 164.59 107.70 76.73 107.97
Equity Share Capital 17.69 17.69 17.69 17.69 17.69
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 8.92 18.70 12.24 8.72 12.27
Diluted EPS 8.92 18.70 12.23 8.72 12.27
EPS After Extra Ordinary
Basic EPS 8.92 18.70 12.24 8.72 12.27
Diluted EPS 8.92 18.70 12.23 8.72 12.27
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for ajantapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.